Home
>
National Drug Code (NDC)
>
Rhizopus oryzae
Rhizopus oryzae - 36987-2080-4 - (Rhizopus oryzae)
Drug Information of Rhizopus oryzae
| Product NDC: | 36987-2080 |
| Proprietary Name: | Rhizopus oryzae |
| Non Proprietary Name: | Rhizopus oryzae |
| Active Ingredient(s): | .1 g/mL & nbsp; Rhizopus oryzae |
| Administration Route(s): | INTRADERMAL; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Rhizopus oryzae
| Product NDC: | 36987-2080 |
| Labeler Name: | Nelco Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA102192 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19720829 |
Package Information of Rhizopus oryzae
| Package NDC: | 36987-2080-4 |
| Package Description: | 50 mL in 1 VIAL, MULTI-DOSE (36987-2080-4) |
NDC Information of Rhizopus oryzae
| NDC Code | 36987-2080-4 |
| Proprietary Name | Rhizopus oryzae |
| Package Description | 50 mL in 1 VIAL, MULTI-DOSE (36987-2080-4) |
| Product NDC | 36987-2080 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Rhizopus oryzae |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRADERMAL; SUBCUTANEOUS |
| Start Marketing Date | 19720829 |
| Marketing Category Name | BLA |
| Labeler Name | Nelco Laboratories, Inc. |
| Substance Name | RHIZOPUS ARRHIZUS VAR. ARRHIZUS |
| Strength Number | .1 |
| Strength Unit | g/mL |
| Pharmaceutical Classes | Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient] |
